Phase I safety, pharmacokinetic, and pharmacodynamic study...

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors

Markman, B., Tabernero, J., Krop, I., Shapiro, G. I., Siu, L., Chen, L. C., Mita, M., Melendez Cuero, M., Stutvoet, S., Birle, D., Anak, O., Hackl, W., Baselga, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
23
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mds011
Date:
September, 2012
File:
PDF, 362 KB
english, 2012
Conversion to is in progress
Conversion to is failed